Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ITP”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04516837
What this trial is testing

Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00621894
What this trial is testing

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Who this might be right for
Immune Thrombocytopenic Purpura
GlaxoSmithKline 23
Large-scale testing (Phase 3)Study completedNCT00774202
What this trial is testing

Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Weill Medical College of Cornell University 17
Not applicableStudy completedNCT01666795
What this trial is testing

Autoantibody Specificity and Response to IVIG in ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Shandong University 672
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738822
What this trial is testing

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Who this might be right for
Immune Thrombocytopenia (ITP)Warm Autoimmune Hemolytic Anemia (WAIHA)
Cullinan Therapeutics Inc. 72
Large-scale testing (Phase 3)Study completedNCT00370331
What this trial is testing

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 197
Not applicableStudy completedNCT04057703
What this trial is testing

Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.

Who this might be right for
Immune Thrombocytopenic PurpuraAutoimmune Hemolytic AnemiaEvan Syndrome+1 more
University Hospital, Bordeaux 454
Not applicableNot Yet RecruitingNCT06790888
What this trial is testing

Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure

Who this might be right for
ITP - Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 78
Testing effectiveness (Phase 2)Study completedNCT00515203
What this trial is testing

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Amgen 22
Large-scale testing (Phase 3)Study completedNCT04687072
What this trial is testing

Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 207
Testing effectiveness (Phase 2)UnknownNCT02338414
What this trial is testing

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Samsung Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00162006
What this trial is testing

Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Baxalta now part of Shire 28
Not applicableStudy completedNCT01974232
What this trial is testing

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 33
Early research (Phase 1)Looking for participantsNCT06826430
What this trial is testing

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06531018
What this trial is testing

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

Who this might be right for
Primary Immune Thrombocytopenia
Renata PLC 100
Large-scale testing (Phase 3)Study completedNCT05029635
What this trial is testing

Phase III Study on HMPL-523 for Treatment of ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Hutchmed 272
Early research (Phase 1)WithdrawnNCT06291415
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaBlood Platelet DisorderHematologic Diseases+14 more
Hutchmed
Not applicableUnknownNCT06466824
What this trial is testing

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Who this might be right for
Primary Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 157
Not applicableLooking for participantsNCT05152238
What this trial is testing

ITP Registry and Accompanying Biospecimen Collection

Who this might be right for
Immune Thrombocytopenia
Jena University Hospital 1,100
Not applicableNo Longer AvailableNCT03363334
What this trial is testing

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals
Next Page